Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGoodwin Regulatory News (GDWN)

Share Price Information for Goodwin (GDWN)

Share Price is delayed by 15 minutes
Get Live Data
14,620.00    80.00 (0.55%)
Bid:
14,600.00
Ask:
14,660.00
Spread: 60.00 (0.411%)
Market Cap: £1.12b
GDWN Live PriceLast checked at - London Stock Exchange

Intraday Goodwin Share Chart

Acquisition

23 Mar 2007 09:15

Goodwin PLC23 March 2007 Goodwin PLC ("Goodwin" or the "Company") 23 March 2007 ACQUISITION OF NOREVA GmbH Goodwin, the mechanical and refractory engineering group, announces theacquisition of 75% of the share capital of Noreva GmbH ("Noreva"), amanufacturer of non return nozzle check valves located in Monchengladbach,Germany for an initial consideration of £2.8 million in cash. In the year to 31 December 2006 Noreva generated turnover of Eur 7.3 million (£5 million), profit before tax of Eur 0.42 million (£0.288 million) and has gross assets of Eur 4.3 million (£2.9 million) audited. The remaining 25% share interest, which is owned equally by the two currentManaging Directors of Noreva, Messrs R. Kurzenberg and M. Sattelberg (the"Managing Directors"), who are to continue to serve Noreva in their presentcapacity following the acquisition, is subject to put options exercisable by the Managing Directors no sooner than 5 years, and a call option exercisable byGoodwin PLC no earlier than 12 years, from the date of completion of theacquisition. The initial consideration is £2.8 million in cash, together with £0.6 millionpayable to Noreva (i.e. funds retained within the Goodwin group) for a perpetualtechnology licence. A deferred consideration of an additional £1.0 million willbe paid in two instalments, payable after three and five years after completion,respectively. The consideration in case of the exercise of the put and/or calloption will be either £1.0 million for the remaining 25 % of the Novera sharesor is to be calculated based on 10 times annual average pre-tax profit of Noreva for three years prior to the exercise of the option, or a combination of both calculation methods, depending on, inter alia, the term of service of therespective Managing Director. The Company believes that Noreva is a complementary business and anticipatessignificant value being created from the excellent synergy in the marketing andproduction capacity opportunities between Noreva and Goodwin's UK basedsubsidiaries Goodwin International Ltd and Goodwin Steel Castings Ltd (the"Goodwin Companies"). The Goodwin Companies manufacture and supply dual platenon-return check valves for the oil and gas industry worldwide, whereas Norevasupplies a complementary but more costly and faster-acting nozzle check valve to applications requiring less backflow and pressure surge. Noreva and the Goodwin Companies will continue to benefit from each others'technology and marketing resources, which are also complementary. Financing fromGoodwin will enable Noreva to extend its facility in Monchengladbach and anagreed cooperation in the area of distribution will enable each company toreduce lead times and provide a faster service to their customers and achieveincreased sales. The acquisition of Noreva will enable the Goodwin Companies and Noreva tofurther strengthen their relative market positions through the ability to offercomplete check valve solutions to their principal markets in the hydrocarbon,processing and water industries. Francis Gaffney, Director and General Manager of Goodwin International Ltd anda main board director of Goodwin PLC, will become a Managing Director of Noreva,together with the existing Managing Directors. Enquiries: John GoodwinTel: +44 1782 220000Goodwin PLC END This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Dec 20084:34 pmRNSDirector/PDMR Shareholding
17th Dec 20085:14 pmRNSHalf Yearly Report
29th Sep 20081:50 pmRNSDirectorate Change
23rd Sep 200810:42 amRNSDirector/PDMR Shareholding
9th Sep 20082:00 pmRNSInterim Management Statement
1st Sep 200812:16 pmRNSDoc re.Report and Accounts
22nd Aug 20084:33 pmRNSFinal Results
30th Jun 20082:32 pmRNSAcquisition of SRS Holdings L
7th Apr 20086:22 pmRNSDirector/PDMR Shareholding
12th Mar 200810:24 amRNSRe Contract
7th Mar 20082:00 pmRNSInterim Management Statement
15th Jan 20085:14 pmRNSDirector/PDMR Shareholding
21st Dec 20075:10 pmRNSDoc re. Interim Accounts
21st Dec 20074:46 pmRNSDirector/PDMR Shareholding
21st Dec 20079:00 amRNSInterim Results
16th Oct 20075:49 pmRNSDirector/PDMR Shareholding
10th Oct 20074:22 pmRNSAnnual Information Update
24th Sep 200710:16 amRNSDoc re. Report and Accounts
14th Sep 20073:00 pmRNSInterim Management Statement
24th Aug 20073:01 pmRNSFinal Results
23rd Mar 20079:15 amRNSAcquisition
30th Jan 20079:45 amRNSDoc re.Unaudited Interim Acct
29th Jan 20075:44 pmRNSDirector/PDMR Shareholding
26th Jan 20079:00 amRNSInterim Results
22nd Dec 20069:14 amRNSAppointment of Directors
8th Dec 200612:13 pmRNSTotal Voting Rights
17th Nov 20063:51 pmRNSDirector/PDMR Shareholding
9th Oct 20066:03 pmRNSAnnual Information Update
25th Sep 20069:09 amRNSDoc re. Report and Accounts
25th Aug 20063:00 pmRNSFinal Results
22nd Jun 20065:50 pmRNSDirector/PDMR Shareholding
26th May 20063:37 pmRNSDirector/PDMR Shareholding
24th Mar 20063:09 pmRNSDirector/PDMR Shareholding
20th Mar 200611:29 amRNSDirectorate Change
30th Jan 20069:40 amRNSDoc re. Interim Accounts
27th Jan 20063:00 pmRNSInterim Results
22nd Nov 20054:37 pmRNSDirector/PDMR Shareholding
10th Nov 200512:36 pmRNSAnnual Information Update
26th Sep 20059:59 amRNSDoc re Report and Accounts
9th Sep 20052:17 pmRNSDirector/PDMR Shareholding
26th Aug 20053:00 pmRNSFinal Results
10th May 20053:26 pmRNSDirector Shareholding
11th Apr 20054:37 pmRNSHolding(s) in Company
7th Apr 200512:39 pmRNSDirector Shareholding
5th Apr 200511:34 amRNSDirector Shareholding-Amend
4th Apr 20055:00 pmRNSDirector Shareholding
31st Mar 20053:06 pmRNSDirector Shareholding
31st Jan 200512:37 pmRNSDoc re Unaudited Interim Acct
28th Jan 20053:00 pmRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.